The clinical data showed that the expression of METTL3 (Fig. 8C) and ZEB2 (Fig. 8D) in RFs was significantly greater than that in adjacent normal tissues from renal cell carcinoma patients. This evidence concerns the gene ZEB2 and renal cell carcinoma.